- Conditions
- Premature Rupture of Membrane, Induction of Labor Affected Fetus / Newborn
- Interventions
- Misoprostol Oral Product, Intravenous Oxytocin
- Drug
- Lead sponsor
- University of Wisconsin, Madison
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 138 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2025
- U.S. locations
- 1
- States / cities
- Madison, Wisconsin
Source: ClinicalTrials.gov public record
Updated Aug 27, 2025 · Synced May 22, 2026, 1:08 AM EDT